As of 2025-06-30, the Relative Valuation of Ose Immunotherapeutics SA (OSE.PA) is 24.56 EUR. This relative valuation is based on P/E multiples. With the latest stock price at 5.08 EUR, the upside of Ose Immunotherapeutics SA based on Relative Valuation is 382.9%.
The range of the Relative Valuation is 14.51 - 36.85 EUR.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 15.1x | 11.9x |
| Forward P/E multiples | 19.0x - 32.6x | 25.8x |
| Fair Price | 14.51 - 36.85 | 24.56 |
| Upside | 185.3% - 624.6% | 382.9% |
| Date | P/E |
| 2025-06-27 | 3.04 |
| 2025-06-26 | 3.04 |
| 2025-06-25 | 3.01 |
| 2025-06-24 | 3.02 |
| 2025-06-23 | 2.88 |
| 2025-06-20 | 2.95 |
| 2025-06-19 | 3.01 |
| 2025-06-18 | 3.04 |
| 2025-06-17 | 3.04 |
| 2025-06-16 | 3.11 |
| 2025-06-13 | 3.03 |
| 2025-06-12 | 3.07 |
| 2025-06-11 | 3.16 |
| 2025-06-10 | 3.28 |
| 2025-06-09 | 3.29 |
| 2025-06-06 | 3.52 |
| 2025-06-05 | 3.61 |
| 2025-06-04 | 3.73 |
| 2025-06-03 | 3.68 |
| 2025-06-02 | 3.75 |
| 2025-05-30 | 3.56 |
| 2025-05-29 | 3.54 |
| 2025-05-28 | 3.55 |
| 2025-05-27 | 3.55 |
| 2025-05-26 | 3.69 |
| 2025-05-23 | 3.63 |
| 2025-05-22 | 3.80 |
| 2025-05-21 | 3.60 |
| 2025-05-20 | 3.71 |
| 2025-05-19 | 3.56 |
| 2025-05-16 | 3.50 |
| 2025-05-15 | 3.50 |
| 2025-05-14 | 3.62 |
| 2025-05-13 | 3.63 |
| 2025-05-12 | 3.56 |
| 2025-05-09 | 3.58 |
| 2025-05-08 | 3.50 |
| 2025-05-07 | 3.59 |
| 2025-05-06 | 3.72 |
| 2025-05-05 | 3.88 |
| 2025-05-02 | 4.03 |
| 2025-04-30 | 3.83 |
| 2025-04-29 | 3.58 |
| 2025-04-28 | 3.46 |
| 2025-04-25 | 3.41 |
| 2025-04-24 | 3.47 |
| 2025-04-23 | 3.41 |
| 2025-04-22 | 3.37 |
| 2025-04-17 | 3.52 |
| 2025-04-16 | 3.56 |